Sarepta offers Exondys 51 outside of the U.S. through a managed access program run by Clinigen, as an EMA decision is expected next year.

Private equity firm EQT is acquiring Certara from Arsenal Capital Partners, a deal that values the CRO at $850 million, Arsenal announced on Tuesday.

INC says it is focused on growing its Asia presence with moves and an expansion.

QuintilesIMS’ Orchestrated Customer Engagement software aims to build synergies among commercial teams.

Veristat finished enrollment for a study sponsored by AOBiome earlier, and that earned it a preferred provider agreement.

Parexel has become the latest CRO to be bought up as the industry continues its M&A bonanza.

OmniComm Systems, which owns early-phase clinical trial electronic data capture software TrialOne, has nailed a major CRO deal worth $11.7 million.

JSR made another major biotech deal to acquire mammalian cell line developer Selexis, planning to combine it with KBI.

Deals